Privately held Dyno Therapeutics Inc. has added another notch to its adeno-associated virus (AAV) vectors development ...

Early results from REFLECTION, a real-world study, mirrored results for Grail Inc.'s multi-cancer early detection (MCED) assay in clinical trials, according to a presentation at the 2024 Early ...

Scientists from different laboratories around the world have presented the latest advances in research into malignant brain tumors at the 31st Annual Congress of the European Society of Gene and Cell ...

Grifols SA has entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to ...

Editas Medicine Inc. has achieved in vivo preclinical proof of concept of hematopoietic stem and progenitor cell (HSPC) ...

In what seems a replay of concerns about technetium shortages from the 2010s, a bipartisan group of members of the U.S. House ...

The EU's regulatory crisis continues to roil relations between Brussels and stakeholders in the health care sector, and the ...

Cellbion Co. Ltd. debuted on the tech-heavy Kosdaq board of the Korea Exchange Oct. 16, with share prices closing upward at ...

Oblique Therapeutics AB has achieved a milestone within its research project on the Nav1.8 ion channel with the goal of ...

Boston Scientific Corp. posted another eye-popping quarterly report, led by a 177% year-over-year increase in its ...

The Japanese government, industry and academia are deliberating health care policies and initiatives to boost Japan’s role in ...

Modifi Biosciences Inc. has come a long way very quickly. Spun out of Yale University in 2021, it published data on DNA in ...